Recently, LMP1 has been shown to enhance EV release through Syndecan-2 and synaptotagmin-like-4 through NF-κB signaling and this promotes cell proliferation, invasion and tumor growth in vivo [54]. The gene discussed is SYTL4; the disease is neoplasm.